The Kaplan–Meier analysis showed that APL patients with higher Gal-3 levels had significant shorter OS and relapse-free survival (RFS), and higher cumulative incidence of relapse than those with lower Gal-3 levels. This evidence concerns the gene LGALS3 and acute promyelocytic leukemia.